Search
01/03/2025
Impact of injection density following water vapor thermal therapy for benign prostatic obstruction
Alejo, AF, Povo, I, Secco, S, Garcia, S, Fernández, E, D'Anna, M, Parejo, V, Torneo, I, Ferrari, G, Varvello, F, de León, JP, Palou, J, Cindolo, L, Schwartzmann, I. Impact of injection density following water vapor thermal therapy for benign prostatic obstruction. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
Robot-assisted versus open kidney transplantation from living donor
Afferi, L, Ortved, M, Dagnaes-Hansen, JA, Masieri, L, Pecoraro, A, Etcheverry, B, Gallioli, A, Cannoletta, D, Territo, A, Vangeneugden, J, Desender, L, Mercier, J, Prudhomme, T, Benitez, NO, Fontana, G, Garcia-Baquero, R, Rohrsted, M, Roder, A, Vigues, F, Doumerc, N, Campi, R, Serni, S, Decaestecker, K, Breda, A. Robot-assisted versus open kidney transplantation from living donor. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
Active surveillance of grade group 2 prostate cancer: Oncological outcomes from a contemporary European cohort
Uleri, A, Leni, R, Oderda, M, Peyrottes, A, Kesch, C, An-Nader, M, Dariane, C, Baud, H, Olivier, J, Sanguedolce, F, Rios, AR, Bernard,, Windisch, O, Valerio, M, Gandaglia, G, Ploussard, G, Baboudjian, M. Active surveillance of grade group 2 prostate cancer: Oncological outcomes from a contemporary European cohort. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
Robot-assisted kidney transplantation (RAKT) using right vs. left kidney: Implications for living donors nefrectomy
Pecoraro, A, Catucci, CL, Territo, A, Gallioli, A, Etcheverry, B, Musquera, M, Prudhomme, T, Zeushner, P, Volpe, A, Baquero, RG, Kocak, B, Mirza, I, Stockle, M, Rohrsted, M, Canda, E, Roder, A, Alcaraz, A, Doumerc, N, Vigues, F, Decaestecker, K, Masieri, L, Serni, S, Breda, A, Campi, R. Robot-assisted kidney transplantation (RAKT) using right vs. left kidney: Implications for living donors nefrectomy. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
Prospective multicenter long-term analysis of oral morbidity after oral mucosa grafts harvesting for substitution or augmentation urethroplasties
Martin, IJP, Guzmán, EF, Polo, MM, Martin, MA, Pascual, EF, Samaniego, MP, Pascual, EM, González, AR, González, BM, Sanz, IP, Jimenez, CP, Bonilla, AS, Morcillo, JCR, Fes, E, Suárez, JMG, Ortega, JL, Roca, JPD, Juanatey, FC. Prospective multicenter long-term analysis of oral morbidity after oral mucosa grafts harvesting for substitution or augmentation urethroplasties. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
Robot-assisted kidney transplantation (RAKT): Surgical and functional outcomes from a large series
Territo, A, Afferi, L, Musquera, M, Sopena, HMG, Pecoraro, A, Campi, R, Gallioli, A, Etcheverry, B, Prudhomme, T, Vangeneugden, J, Ortved, M, Roder, A, Zeuschner, P, Volpe, A, Garcia-Baquero, R, Kocak, B, Mirza,, Fornara, P, Doumerc, N, Decaestecker, K, Serni, S, Vigues, F, Alcaraz, A, Breda, A. Robot-assisted kidney transplantation (RAKT): Surgical and functional outcomes from a large series. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
SISE matters: A novel approach to hands-on training by the European Association of Urology (EAU)
De Oliveira, TMR, Somani, B, Browers, T, Veneziano, D, Redorta, JP, Biyani, CS, Kallidonis, P, Kasivisvanathan,, Zondervan, P, Petrut, B, Verze, P, Phe, VR, Raison, N, Silay, MS, Larche, A, Boissier, R, Liatsikos, E. SISE matters: A novel approach to hands-on training by the European Association of Urology (EAU). EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
A Phase 1/2 study of detalimogene voraplasmid (EG-70) intravesical monotherapy for patients with high-risk non-muscle invasive bladder cancer-Trial in progress
Guerrero-Ramos, F, Chang, S, Dickstein, RJ, Jayram, G, Johnson, S, Joshi, S, Liu, JJ, Lotan, Y, Marcq, G, Satkunasivam, R, Schuckman, A, Steinberg, G, Taylor, J, Linback, T, Pruthi, R, Cheung, A, Tosone, C, Kamat, AM, Palou, J. A Phase 1/2 study of detalimogene voraplasmid (EG-70) intravesical monotherapy for patients with high-risk non-muscle invasive bladder cancer-Trial in progress. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).